VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Clinical trial NCT01950325 · COMPLETED
Trial details
- NCT number
- NCT01950325
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-22
- Primary completion
- 2015-08-20
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.